Ethyl 7-(bis(tert-butoxycarbonyl)amino)-5-chloro-6-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate

Catalog No. :
ACGAIO169
CAS No. :
2271471-16-8
Molecular Formula :
C20H27ClN4O6
Molecular Weight :
454.91

IUPAC Name:ethyl 7-(bis(tert-butoxycarbonyl)amino)-5-chloro-6-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate

Ethyl 7-(bis(tert-butoxycarbonyl)amino)-5-chloro-6-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 7-(bis(tert-butoxycarbonyl)amino)-5-chloro-6-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate
IUPAC Nameethyl 7-(bis(tert-butoxycarbonyl)amino)-5-chloro-6-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate
MDL No.MFCD33401658
Molecular FormulaC20H27ClN4O6
Molecular Weight454.91
SMILESO=C(C1=C2N=C(Cl)C(C)=C(N(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)N2N=C1)OCC
InChI KeyXLGZZENOUFXNNN-UHFFFAOYSA-N
SynonymPyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 7-[bis[(1,1-dimethylethoxy)carbonyl]amino]-5-chloro-6-methyl-, ethyl ester;Ethyl 7-(bis(tert-butoxycarbonyl)amino)-5-chloro-6-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate;Ethyl 5-Chloro-7-[bis(Boc)amino]-6-methylpyrazolo[1,5-a]pyrimidine-3-carboxylate
CAS No.2271471-16-8

Synthetic Route by SureRoute

1. ACGAIO169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGAIO169 route product structure diagram
    ACGAIO1692271471-16-8
Inquiry

2. ACGAIO169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGAIO169 route product structure diagram
    ACGAIO1692271471-16-8
Inquiry

Comments (0)